Given that pancreatic cancer stemness negatively regulated anti-cancer immunity, we screened out CEACAM5, which was highly expressed in the high mRNAsi score group, among the 37 selected inhibitory immune checkpoint genes (Fig. 2B). The gene discussed is CEACAM5; the disease is pancreatic neoplasm.